Ningbo MedicalSystem (China) Performance
| 300439 Stock | 11.61 0.11 0.96% |
On a scale of 0 to 100, Ningbo MedicalSystem holds a performance score of 10. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Ningbo MedicalSystem are completely uncorrelated. Please check Ningbo MedicalSystem's total risk alpha, maximum drawdown, and the relationship between the standard deviation and sortino ratio , to make a quick decision on whether Ningbo MedicalSystem's current price movements will revert.
Risk-Adjusted Performance
10 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0115 | Payout Ratio 0.229 | Last Split Factor 30:10 | Forward Dividend Rate 0.13 | Ex Dividend Date 2024-06-07 |
1 | United States Procalcitonin Market by Type Segmentation - Third Eye News | 09/23/2024 |
| Begin Period Cash Flow | 783.9 M |
Ningbo |
Ningbo MedicalSystem Relative Risk vs. Return Landscape
If you would invest 929.00 in Ningbo MedicalSystem Biotechnology on September 1, 2024 and sell it today you would earn a total of 232.00 from holding Ningbo MedicalSystem Biotechnology or generate 24.97% return on investment over 90 days. Ningbo MedicalSystem Biotechnology is generating 0.4437% of daily returns and assumes 3.4887% volatility on return distribution over the 90 days horizon. Simply put, 31% of stocks are less volatile than Ningbo, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Ningbo MedicalSystem Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ningbo MedicalSystem's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ningbo MedicalSystem Biotechnology, and traders can use it to determine the average amount a Ningbo MedicalSystem's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1272
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300439 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.49 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.44 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Ningbo MedicalSystem is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ningbo MedicalSystem by adding it to a well-diversified portfolio.
Ningbo MedicalSystem Fundamentals Growth
Ningbo Stock prices reflect investors' perceptions of the future prospects and financial health of Ningbo MedicalSystem, and Ningbo MedicalSystem fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ningbo Stock performance.
| Return On Equity | 0.0933 | ||||
| Return On Asset | 0.0348 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 3.67 B | ||||
| Shares Outstanding | 383.95 M | ||||
| Price To Book | 1.54 X | ||||
| Price To Sales | 2.45 X | ||||
| Revenue | 1.89 B | ||||
| Gross Profit | 949.62 M | ||||
| EBITDA | 330.95 M | ||||
| Net Income | 256.55 M | ||||
| Total Debt | 50.05 M | ||||
| Book Value Per Share | 7.53 X | ||||
| Cash Flow From Operations | 633.53 M | ||||
| Earnings Per Share | 0.65 X | ||||
| Total Asset | 3.49 B | ||||
| Retained Earnings | 1.13 B | ||||
About Ningbo MedicalSystem Performance
By analyzing Ningbo MedicalSystem's fundamental ratios, stakeholders can gain valuable insights into Ningbo MedicalSystem's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ningbo MedicalSystem has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ningbo MedicalSystem has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ningbo MedicalSystem is entity of China. It is traded as Stock on SHE exchange.Things to note about Ningbo MedicalSystem performance evaluation
Checking the ongoing alerts about Ningbo MedicalSystem for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ningbo MedicalSystem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ningbo MedicalSystem had very high historical volatility over the last 90 days | |
| Ningbo MedicalSystem is unlikely to experience financial distress in the next 2 years | |
| About 49.0% of the company shares are owned by insiders or employees |
- Analyzing Ningbo MedicalSystem's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ningbo MedicalSystem's stock is overvalued or undervalued compared to its peers.
- Examining Ningbo MedicalSystem's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ningbo MedicalSystem's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ningbo MedicalSystem's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ningbo MedicalSystem's stock. These opinions can provide insight into Ningbo MedicalSystem's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ningbo Stock analysis
When running Ningbo MedicalSystem's price analysis, check to measure Ningbo MedicalSystem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ningbo MedicalSystem is operating at the current time. Most of Ningbo MedicalSystem's value examination focuses on studying past and present price action to predict the probability of Ningbo MedicalSystem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ningbo MedicalSystem's price. Additionally, you may evaluate how the addition of Ningbo MedicalSystem to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |